Torre D, Broggini M, Rossi S, Sampietro C, Bottà V
Division of Infectious Diseases, Regional Hospital, Varese, Italy.
Int J Tissue React. 1989;11(1):27-9.
The effect of rokitamycin on human polymorphonuclear leukocyte (PMNL) chemotaxis was studied in vitro and in vivo. It was found that rokitamycin in vitro at a concentration of 20 micrograms/ml caused a diminution of PMNL migration, while at lower concentrations no significant effects on migration was observed. In in-vivo studies before and after the ingestion of rokitamycin by six healthy individuals, no change on PMNL chemotaxis was found.
